Literature DB >> 27790923

Consideration of the ethnic prevalence of genotypes in the clinical use of tacrolimus.

Louise M Andrews1, Brenda Cm De Winter1, Teun Van Gelder1,2, Dennis A Hesselink2.   

Abstract

Entities:  

Keywords:  CYP3A5; ethnicity; tacrolimus; transplantation

Mesh：

Substances：

Year:  2016        PMID： 27790923     DOI： 10.2217/pgs-2016-0136

Source DB:  PubMed          Journal:  Pharmacogenomics        ISSN： 1462-2416            Impact factor:   2.533


× No keyword cloud information.
  11 in total

1.  Tacrolimus Trough Concentration Variability and Disparities in African American Kidney Transplantation.

Authors:  David J Taber; Zemin Su; James N Fleming; John W McGillicuddy; Maria A Posadas-Salas; Frank A Treiber; Derek Dubay; Titte R Srinivas; Patrick D Mauldin; William P Moran; Prabhakar K Baliga
Journal:  Transplantation       Date:  2017-12       Impact factor: 4.939

Review 2.  Clinical aspects of tacrolimus use in paediatric renal transplant recipients.

Authors:  Agnieszka Prytuła; Teun van Gelder
Journal:  Pediatr Nephrol       Date:  2018-02-26       Impact factor: 3.714

3.  Association of Intrapatient Variability of Tacrolimus Concentration With Early Deterioration of Chronic Histologic Lesions in Kidney Transplantation.

Authors:  Hyejin Mo; Song-Yi Kim; Sangil Min; Ahram Han; Sanghyun Ahn; Seung-Kee Min; Hajeong Lee; Curie Ahn; Yonsu Kim; Jongwon Ha
Journal:  Transplant Direct       Date:  2019-05-22

4.  A population pharmacokinetic model to predict the individual starting dose of tacrolimus in adult renal transplant recipients.

Authors:  L M Andrews; D A Hesselink; R H N van Schaik; T van Gelder; J W de Fijter; N Lloberas; L Elens; D J A R Moes; B C M de Winter
Journal:  Br J Clin Pharmacol       Date:  2019-01-17       Impact factor: 4.335

5.  Efficacy and safety of prolonged-release tacrolimus in stable pediatric allograft recipients converted from immediate-release tacrolimus - a Phase 2, open-label, single-arm, one-way crossover study.

Authors:  Jacek Rubik; Dominique Debray; Deirdre Kelly; Franck Iserin; Nicholas J A Webb; Piotr Czubkowski; Karel Vondrak; Anne-Laure Sellier-Leclerc; Christine Rivet; Silvia Riva; Burkhard Tönshoff; Lorenzo D'Antiga; Stephen D Marks; Raymond Reding; Gbenga Kazeem; Nasrullah Undre
Journal:  Transpl Int       Date:  2019-08-27       Impact factor: 3.782

6.  Effect of Concentration/Dose Ratio in De Novo Kidney Transplant Recipients Receiving LCP-Tacrolimus or Immediate-Release Tacrolimus: Post Hoc Analysis of a Phase 3 Clinical Trial.

Authors:  Barbara Suwelack; Suphamai Bunnapradist; Ulf Meier-Kriesche; Daniel R Stevens; Claudio Procaccianti; Roberto Morganti; Klemens Budde
Journal:  Ann Transplant       Date:  2020-07-28       Impact factor: 1.530

7.  Post-transplant Diabetes Mellitus in Kidney Transplant Recipients in Sudan: A Comparison Between Tacrolimus and Cyclosporine-Based Immunosuppression.

Authors:  Elamein Yousif; Abdelrahman Abdelwahab
Journal:  Cureus       Date:  2022-02-16

8.  A Population Pharmacokinetic Model Does Not Predict the Optimal Starting Dose of Tacrolimus in Pediatric Renal Transplant Recipients in a Prospective Study: Lessons Learned and Model Improvement.

Authors:  Louise M Andrews; Brenda C M de Winter; Elisabeth A M Cornelissen; Huib de Jong; Dennis A Hesselink; Michiel F Schreuder; Roger J M Brüggemann; Teun van Gelder; Karlien Cransberg
Journal:  Clin Pharmacokinet       Date:  2020-05       Impact factor: 6.447

9.  Beyond Single Nucleotide Polymorphisms: CYP3A5∗3∗6∗7 Composite and ABCB1 Haplotype Associations to Tacrolimus Pharmacokinetics in Black and White Renal Transplant Recipients.

Authors:  Daniel A Brazeau; Kristopher Attwood; Calvin J Meaney; Gregory E Wilding; Joseph D Consiglio; Shirley S Chang; Aijaz Gundroo; Rocco C Venuto; Louise Cooper; Kathleen M Tornatore
Journal:  Front Genet       Date:  2020-08-11       Impact factor: 4.599

10.  Race and sex associations with tacrolimus pharmacokinetics in stable kidney transplant recipients.

Authors:  Kathleen M Tornatore; Calvin J Meaney; Kristopher Attwood; Daniel A Brazeau; Gregory E Wilding; Joseph D Consiglio; Aijaz Gundroo; Shirley S Chang; Vanessa Gray; Louise M Cooper; Rocco C Venuto
Journal:  Pharmacotherapy       Date:  2022-02-01       Impact factor: 6.251
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.